CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- 4/A Open-market buy Director bought 45,280 shares at $1.04 ($47,168)
- 4 Grant or award Chief Medical Officer acquired 157,088 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 197,368 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 162,281 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,083,334 shares (grant or award)
- 4 Grant or award Director acquired 2,716,898 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 22,640 shares at $1.04 ($23,584)
- 4 Open-market buy Chief Medical Officer bought 9,056 shares at $1.04 ($9,434)
- 4 Open-market buy Director bought 90,562 shares at $1.04 ($94,338)
- 4 Open-market buy Director bought 36,224 shares at $1.04 ($37,735)
- 4 Open-market buy Director bought 9,056 shares at $1.04 ($9,434)
- 4 Open-market buy Chief Operating Officer bought 9,056 shares at $1.04 ($9,434)
- 4 Open-market buy Chief Financial Officer bought 9,056 shares at $1.04 ($9,434)
- 4 Open-market buy Director bought 1,358,448 shares at $1.04 ($1,415,095)
- 4 Returned to the company Chief Executive Officer returned 10,261 shares (to the company)
- 4 Returned to the company Chief Medical Officer returned 2,975 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 1,150 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 258 shares (to the company)
- 4 Returned to the company Chief Operating Officer returned 1,130 shares (to the company)
- 4 Open-market buy Director bought 300,000 shares at an average $0.17 ($50,000)
Page 5 of 14 · 269 filings